News

OncoRes Medical receives $150,000 funding boost from Western Australian Government

22 January 2021

With health policy top of the political agenda, now’s the time to supercharge Australia’s biotech sector says new MRCF Board member

21 December 2020

Erica Kneipp tapped for $700m biotech fund

21 December 2020

Research on preventative nasal spray, which protects against COVID-19 and common cold, published in leading peer-reviewed academic journals

18 December 2020

Nasal spray which could fight Covid and other respiratory infections gets funding

22 November 2020

New investments for drug research

17 November 2020

Myricx Pharma Launches with £4.5M (AU$8.2M) Financing to Progress its Novel NMT inhibitors in Cancer

16 November 2020

PolyActiva successfully completes initial clinical trial with Latanoprost FA SR Ocular Implant delivering glaucoma treatment to patients over a six-month period

6 November 2020

Aravax appoints Financial Executive Thomas Ulmer to Board of Directors

1 November 2020

OncoRes Medical wins IGNITE Madness 2020

29 October 2020

Eyeing pandemic’s silver lining for drug trials

26 October 2020

Azura Ophthalmics raises AUD$28m for registration studies for treatment of leading cause of dry eye disease

23 October 2020

Vaxxas Announces US$22 Million (A$30.6 Million) Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response

5 October 2020

Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study

28 September 2020

Nasal spray cuts COVID-19 growth, study shows

28 September 2020

Biomedical Translation Bridge Program grants $1m to develop a drug treatment for obesity-related health conditions

3 September 2020

GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI)

30 July 2020

OncoRes Medical awarded prestigious research funding

22 July 2020

Innovative type two diabetes treatment scores $29m

12 June 2020

$29M investment to develop new treatment for type 2 diabetes

12 June 2020

Vaxxas announces that MSD Exercises Option to Apply Novel Immune System Activation Platform for Vaccine Candidate

29 May 2020

Harro Höfliger and Vaxxas Announce Alliance to Develop Industrial‐scale Aseptic Processing Line for Vaccine Products Based on Vaxxas’ High Density Microarray Patch (HD‐MAP)

28 May 2020

Nation faces ‘generational loss’ of biotechs warning

25 May 2020

Urgent COVID-19 response package needed to support and protect $170b life sciences sector

8 May 2020

Bill Ferris, pioneer venture capitalist, appointed Chair of the MRCF

24 March 2020

Vaxxas High-Density Microarray Patch to Efficiently Deliver Vaccines Directly to Skin

18 March 2020

Vaxxas Awarded US$5 million Grant for Clinical Study of Measles and Rubella Vaccination

18 March 2020

Multi-million-dollar mission to tackle major global health challenges

10 March 2020

MRCF establishes life science incubator to boost NZ startup successes

16 December 2019

QUE Oncology recruiting Sydney breast cancer patients experiencing hot flushes & night sweats

23 October 2019

$14m invested in University of Melbourne spin-out to create vaccine for periodontal gum disease

26 September 2019

FDA Grants EBR Systems Breakthrough Device Designation Status for the WiSE Cardiac Resynchronization Therapy (CRT) System

10 September 2019

Perth tech joint-winner in global finals for international start-up competition

28 August 2019

EBR Systems Closes $30M in New Funding, John McCutcheon Joins Company as President and CEO

27 August 2019

Q-Sera’s innovative blood clotting technology granted patent in US

20 August 2019

QUE Oncology launches Phase II trials in New Zealand

1 August 2019

QUE Oncology Appoints Dr. Julie Cherrington and Elizabeth Cermak to Board of Directors

29 July 2019

PolyActiva completes recruitment in key Phase I glaucoma implant safety study.

23 July 2019

Morphoseq™ at ‘Sequencing, Finishing and Analysis in the Future’ meeting, USA

22 May 2019

Longas Launches, Unveiling Morphoseq™ Long Read DNA Sequencing Technology

16 May 2019

Brandon Capital Partners launches new Medical Research Commercialisation Fund, seeks NZ institutional

1 May 2019

QUE Oncology launches Phase II trials in the United States

2 April 2019

MRCF launches Perth-based biotech developing new treatment for Cystic Fibrosis

15 March 2019

Aravax reveals positive Phase I trial results at world-leading allergy conference

25 February 2019

Australian Phase II trial commences for potential world-first treatment of viral conjunctivitis

31 January 2019

Perth tech takes out Australian start-up competition to join international finals

3 December 2018

The WILD Program launches within the Victorian STEM sector, with first intake of 20 women

21 November 2018

QUE Oncology launches Phase II trials

2 October 2018

PolyActiva commences first Phase I clinical trial with potential to improve lives of millions

31 August 2018

Paragen Bio launches in northern Queensland with $6 million investment

14 August 2018

Azura Ophthalmics receives Series B funding to create treatment for major cause of Dry Eye Disease

3 July 2018

MRCF announces largest investment to date by Biotechnology Translation Fund

4 June 2018

Brandon Capital’s MRCF announces largest investment by Biotechnology Translation Fund

4 June 2018

Okogen receives $13 Million Series A Funding for trials to treat the leading cause of eye infections

28 February 2018

MRCF invests in San Diego ophthalmic biotech company, clinical trials to take place in Australia

28 February 2018

Australian biotech company launched with AU$7m investment to develop therapies for treating obesity

19 February 2018

Australian biotech company launched with AU$7m investment to develop therapies for treating obesity

19 February 2018

Allergan to Acquire Elastagen to Access Next Generation Injectable Portfolio

2 February 2018

New Zealand biomedical discovery set to revolutionise the global pain relief drug market

22 January 2021

21 December 2020

21 December 2020

18 December 2020

22 November 2020

17 November 2020

16 November 2020

6 November 2020

1 November 2020

29 October 2020

26 October 2020

23 October 2020

5 October 2020

28 September 2020

28 September 2020

3 September 2020

30 July 2020

22 July 2020

12 June 2020

12 June 2020

29 May 2020

28 May 2020

25 May 2020

8 May 2020

24 March 2020

18 March 2020

18 March 2020

10 March 2020

16 December 2019

23 October 2019

26 September 2019

10 September 2019

28 August 2019

27 August 2019

20 August 2019

1 August 2019

29 July 2019

23 July 2019

22 May 2019

16 May 2019

1 May 2019

2 April 2019

15 March 2019

25 February 2019

31 January 2019

3 December 2018

21 November 2018

2 October 2018

31 August 2018

14 August 2018

3 July 2018

4 June 2018

4 June 2018

28 February 2018

28 February 2018

19 February 2018

19 February 2018

2 February 2018

13 December 2017

Contact Us

Melbourne

Palo Alto

Sydney

For media inquiries, contact